Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Common Equity (2016 - 2025)

Chemours (CC) has 12 years of Common Equity data on record, last reported at $251.0 million in Q4 2025.

  • For Q4 2025, Common Equity fell 56.04% year-over-year to $251.0 million; the TTM value through Dec 2025 reached $251.0 million, down 56.04%, while the annual FY2025 figure was $251.0 million, 56.04% down from the prior year.
  • Common Equity reached $251.0 million in Q4 2025 per CC's latest filing, down from $274.0 million in the prior quarter.
  • Across five years, Common Equity topped out at $1.8 billion in Q2 2024 and bottomed at -$15.0 million in Q1 2024.
  • Average Common Equity over 5 years is $789.6 million, with a median of $831.0 million recorded in 2021.
  • Peak YoY movement for Common Equity: crashed 102.0% in 2024, then skyrocketed 3873.33% in 2025.
  • A 5-year view of Common Equity shows it stood at $1.1 billion in 2021, then increased by 2.22% to $1.1 billion in 2022, then tumbled by 34.81% to $721.0 million in 2023, then dropped by 20.8% to $571.0 million in 2024, then crashed by 56.04% to $251.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $251.0 million in Q4 2025, $274.0 million in Q3 2025, and $228.0 million in Q2 2025.